Beating the Market since Inception. (Jan. 2, 2000)
Our Strategies work regardless of market direction or economic conditions
Big Pharma Outperforming: PPH BMY MRK
October 21, 2009
BY Rick Pendergraft:
Contributor, Stock Traders Daily
Real Time Trading Reports: Included are detailed trading reports designed to help investors realize opportunities in these companies as earnings are released. The reports are linked to the stock symbols in the article below. Performance - Click Here
(La Jolla, CA) Large-cap pharmaceutical companies have delivered some impressive earnings results so far this earnings season, but the price performance hasn’t necessarily been as impressive. The Pharmaceutical HOLDRs Trust (NYSE: PPH) has moved to the upper rail of its trend channel, but most of the move came before earnings started getting released.
.jpg)
Two of the ten largest pharmaceutical companies in the United States will release earnings on Thursday before the market opens and these two reports will certainly have an impact on the PPH.
Bristol-Myers Squibb (NYSE: BMY) is expected to earn $0.51 per share, a five cent decline from the $0.56 the company earned last quarter. With all the companies that have fallen short in one earnings report or another in the past year, BMY has managed to meet or exceed expectations in each of the last four quarters. Despite the ability to deliver better earnings reports than analysts have forecasted, the sentiment towards the company isn’t overly optimistic. From a technical perspective, BMY is facing resistance at the $23.25 level. What should you do with BMY? Check out our free report to learn more.
Also releasing earnings on Thursday morning is Merck & Company (NYSE: MRK) and the company is expected to earn $0.82 per share. This is an improvement over the $0.77 per share the company earned last quarter. Unlike BMY, Merck has not always been able to meet expectations as the company missed in the first quarter. Like Bristol-Myers, MRK is facing resistance, with the 100-week moving average resting just over the current price level. The sentiment towards Merck is more optimistic than what we see on BMY, so it will take a more impressive earnings report to move the stock higher. To get a more in depth view, request our report on Merck.
Headlines and Special Reports:
- On The Move: LHO, HST, XRX, ABT, JNPR
- Lower Prices and Better Products: MSFT, SNE, NTDOY, ERTS
- On the Move: URE, UNG, UYM, FSLR
- Battle for Center Stage – AAPL, PALM, RIMM, VZ
- The Post-Labor Day Trade: SPY, C, BAC, FNM, FRE
- Inflation is coming: GLD, UGL, DGL, PST, TBT
- Beginning of Consolidations: CAL, AMR, UAUA, XAL
- Talk Up The Dow, Not The Economy: BAC, F, GS, XOM
- The Next Chapter in the Google vs. Microsoft Rivalry: GOOG, MSFT, AMZN, AAPL
10 Day Free Trial Offer
(you can cancel at any time)Here are a few of the services we offer. Sign up for a Free Trial to find out more.
Buy and Hold is Dead
- No time to control risk?
- Lacking the discipline to do it right?
- Trend Tracker is the solution.
Trend Tracker allows everyone to control risk and realize opportunities regardless of market direction or economic conditions, and without sacrificing time or lifestyle. Work, play golf, or trade other stocks and feel confident that your wealth is protected, and you are positioning yourself to make money.
Anyone, even people with normal jobs, can use Trend Tracker to bring the paradigm of risk control to their investment decisions from this point forward. From now on, your efforts will be easy, efficient, and results - driven.
Sign up for a free trial to learn more.
Empower your competitive Advantage:
Buy and Hold is Dead! You must assume the responsibility of risk control for yourself, and become a Proactive Investor. Money managers are more concerned with generating fees, they are paid to invest money, they do not control risk. Everyone realized that again in 2008. It is a repetitive lesson that some investors will never learn.
Diversification is a great approach when the market is increasing, but that strategy has not worked since 2000, and it is not likely to start working again anytime soon. The Investment Rate proves it. Know what is says.
Stop being at the mercy of the Market, and empower your competitive advantages today. We will teach you how to do it effectively and efficiently so you will never be at the mercy of the Market again.
Thomas H. Kee Jr., President
The Investment Rate is the most accurate leading longer term stock market and economic indicator ever developed. It is the foundation of everything we do. The IR measures the rate of change in the amount of new money available for investment into our economy every year, and for extended periods of time. If has predicted the Great Depression, the Stagflation Period of the 1970s, and the up-periods in between. It impacts all asset classes: stocks, real estate, private business, and any other asset class that relies on new money to grow. Use it to make investment decisions and business decisions. The accuracy is unparalleled. Find out what it says about the immediate future by signing up for a free trial, and see if your decisions line up with the most accurate leading economic indicator in history.
Most money managers do not control risk. They get paid to invest money, not to move it to cash. You must control your own risk; you have to. This is not an option. However, it does not have to be complicated either. Our services are designed to make the transition to risk control seamless. We all know we should do it, now anyone can do it. All of our strategies are focused on risk control and wealth preservation. Performance is a natural byproduct. Stop chasing performance, and start chasing risk control. You will be happier, and better off. Sign up for a free trial to see how our services can make risk control and opportunity paradigm for you too.
A revolution in rule based trading. Trend Tracker is an
automated - correlated market timing and stock selection tool
that allows normal people, with normal jobs, to control their
risk and realize opportunities regardless of economic conditions
or market direction, and without sacrificing time or lifestyle.
Work, play golf, or trade other stocks, and feel confident that
your wealth is being protected and that you are positioning
yourself to profit when opportunities arise.
Sign up for a free trial to learn more.
We offer trading reports on 1300 different companies through Reuters.